// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

SURGICAL PERFORMANCE AS A PREDICTOR OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES IN ROBOTIC PROSTATECTOMY

Mitchell Goldenberg - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

TOWARDS OPTIMIZING SIMULATION-BASED TRAINING FOR PERCUTANEOUS NEPHROLITHOTOMY: A PROSPECTIVE COMPARATIVE STUDY

Ahmed Ibrahim - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A NEW GENERATION OF N-TERMINAL DOMAIN ANDROGEN RECEPTOR INHIBITORS IN CASTRATION-RESISTANT PROSTATE CANCER MODELS

Ronan Le Moigne - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Androgen Tear

COMBINATION THERAPY FOR CASTRATION-RESISTANT PROSTATE CANCER USING ANTAGONISTS OF THE N-TERMINAL DOMAIN OF ANDROGEN RECEPTOR WITH IONIZING RADIATION

Yusuke Ito - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

Androgen Tear

ANALYSIS OF FORCES IN LAPAROSCOPY: THE DECONSTRUCTION OF AN INTRACORPOREAL SUTURING TASK

Kai-Ho Fok - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

DEVELOPMENT, IMPLEMENTATION, AND EVALUATION OF A COMPETENCY-BASED DIDACTIC AND SIMULATION-FOCUSED BOOT CAMP FOR INCOMING UROLOGY RESIDENTS: REPORT OF FIRST TWO YEARS

Yuding Wang - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

UTILITY AND FEASIBILITY OF VIDEO-BASED ASSESSMENT FOR URETEROSCOPY AND LASER LITHOTRIPSY

Yuding Wang - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

WINDOW OF OPPORTUNITY STUDY EVALUATING THE ANTIPROLIFERATIVE EFFECTS OF NEOADJUVANT METFORMIN PLUS SIMVASTATIN PRIOR TO RADICAL CYSTECTOMY FOR BLADDER CANCER: INTERIM ANALYSIS SHOWS REDUCTION IN PI3K/AKT/MTOR SIGNALING PATHWAY

Victor McPherson - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Bladder Cancer

Simvastatin

PSYCHOLOGICAL MORBIDITY ASSOCIATED WITH A NEW DIAGNOSIS OF PROSTATE CANCER: RATES AND PREDICTORS OF DEPRESSIVE SYMPTOMS IN THE RADICAL PC STUDY

Gagan Fervaha - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

MIRABEGRON AND THE RISK OF ARRHYTHMIAS: A POPULATION-BASED COHORT STUDY

Rano Matta - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Arrhythmia

Mirabegron

DIAGNOSIS AND MANAGEMENT OF TESTOSTERONE DEFICIENCY - COMPARISON OF CURRENT GUIDELINES

Jethro C.C. Kwong - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

TRENDS IN DIAGNOSIS AND INITIAL MANAGEMENT OF LOCALIZED PROSTATE CANCER: A RETROSPECTIVE POPULATION-BASED TIME SERIES ANALYSIS WITHIN THE PROVINCE OF ONTARIO

Marian S. Wettstein - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

DISEASE-SPECIFIC COSTS OF NONMETASTATIC AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER IN QUEBEC

Ivan Yanev - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic castration-resistant prostate cancer

N/A

ONCOLOGICAL OUTCOMES OF PATIENTS WITH SPORADIC, NON-METASTATIC RENAL CELL CARCINOMA WITH RENAL VEIN OR INFERIOR VENA CAVA TUMOR THROMBUS

Benjamin Shiff - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Metastatic Renal Cell Cancer

N/A

PATIENT-CENTERED RECONSTRUCTION AND EVALUATION OF PROSTATE CANCER INFORMATION MATERIALS

Alexander E Kiciak - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

THE EFFECT OF SELECTIVE BLADDER DENERVATION IN FEMALE REFRACTORY OVERACTIVE BLADDER WITH OR WITHOUT DETRUSOR OVERACTIVITY

Raphaalle Briere - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Urology

Overactive Bladder

N/A

THE LONG-TERM OUTCOMES OF GRADE GROUPS 2 AND 3 PROSTATE CANCER MANAGED BY ACTIVE SURVEILLANCE: RESULTS FROM A LARGE POPULATION-BASED COHORT

Patrick Richard - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

A NOVEL PREDICTOR OF CLINICAL PROGRESSION IN PATIENTS ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER

Guan Hee Tan - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Prostate cancer

N/A

PREDICTIVE VALUE AND POTENTIALS FOR CO-TARGETED THERAPY OF STAT1 SIGNALING IN GEMCITABINE/CISPLATIN RESISTANT BLADDER CANCER

Tetsutaro Hayashi - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Bladder Cancer

Gemcitabine

PATTERNS OF CARE AND OUTCOMES AROUND TRANSITION IN PATIENTS WITH SPINAL DYSRAPHISM: A POPULATION-BASED STUDY IN ONTARIO, CANADA

Rano Matta - American Urological Association (AUA) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Spina bifida

N/A

Copyright © 2026. QuantiNova All rights reserved